Teladoc Health (NYSE:TDOC) Price Target Lowered to $6.00 at Citigroup

Teladoc Health (NYSE:TDOC) had its price target lowered by Citigroup from $9.00 to $6.00 in a research note published on Tuesday,Benzinga reports. The brokerage currently has a neutral rating on the health services provider’s stock.

Other analysts have also recently issued research reports about the company. BMO Capital Markets dropped their target price on Teladoc Health from $8.00 to $5.00 and set a “market perform” rating on the stock in a research report on Thursday, February 26th. Oppenheimer dropped their price objective on shares of Teladoc Health from $12.00 to $7.00 and set an “outperform” rating on the stock in a report on Tuesday. Piper Sandler reiterated an “overweight” rating and issued a $9.00 price target (down from $12.00) on shares of Teladoc Health in a report on Thursday, February 26th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Teladoc Health in a research report on Monday, December 29th. Finally, Canaccord Genuity Group decreased their price objective on Teladoc Health from $12.00 to $10.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Five analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and an average target price of $7.56.

Teladoc Health Price Performance

Shares of TDOC stock opened at $5.09 on Tuesday. Teladoc Health has a twelve month low of $4.40 and a twelve month high of $9.90. The company has a current ratio of 2.77, a quick ratio of 2.67 and a debt-to-equity ratio of 0.72. The stock has a fifty day simple moving average of $5.90 and a two-hundred day simple moving average of $7.17. The stock has a market capitalization of $908.06 million, a price-to-earnings ratio of -4.46 and a beta of 2.13.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 25th. The health services provider reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.19) by $0.05. Teladoc Health had a negative return on equity of 9.13% and a negative net margin of 7.92%.The firm had revenue of $642.27 million for the quarter, compared to analyst estimates of $635.33 million. During the same quarter last year, the firm posted ($0.28) earnings per share. The business’s revenue for the quarter was up .3% on a year-over-year basis. Teladoc Health has set its Q1 2026 guidance at -0.450–0.350 EPS and its FY 2026 guidance at -1.100–0.700 EPS. On average, analysts predict that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In other news, CEO Charles Divita III sold 17,138 shares of the company’s stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $7.63, for a total transaction of $130,762.94. Following the completion of the transaction, the chief executive officer directly owned 201,036 shares of the company’s stock, valued at $1,533,904.68. This represents a 7.86% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 0.58% of the stock is owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in TDOC. Teacher Retirement System of Texas lifted its stake in shares of Teladoc Health by 5.7% during the 2nd quarter. Teacher Retirement System of Texas now owns 26,592 shares of the health services provider’s stock worth $232,000 after purchasing an additional 1,431 shares during the period. Federated Hermes Inc. increased its stake in Teladoc Health by 0.5% in the third quarter. Federated Hermes Inc. now owns 307,700 shares of the health services provider’s stock valued at $2,379,000 after purchasing an additional 1,450 shares during the last quarter. Creative Planning lifted its position in Teladoc Health by 7.7% during the third quarter. Creative Planning now owns 20,567 shares of the health services provider’s stock worth $159,000 after buying an additional 1,462 shares during the period. Krane Funds Advisors LLC boosted its stake in Teladoc Health by 13.4% in the 3rd quarter. Krane Funds Advisors LLC now owns 12,431 shares of the health services provider’s stock worth $106,000 after buying an additional 1,469 shares during the last quarter. Finally, State of Wyoming grew its holdings in Teladoc Health by 2.1% in the 3rd quarter. State of Wyoming now owns 79,075 shares of the health services provider’s stock valued at $611,000 after buying an additional 1,628 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.